Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
|Videos|October 14, 2014
Developing Excellence in Specialty Pharmacy
Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses MedImpact's Centers of Excellence program.
Advertisement
Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses MedImpact's Centers of Excellence program.
Advertisement
Related to this article
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
3
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5